2 terminated, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
Follow Polysorbates: new trials by email Literature Review of Polysorbates trials Research Report on Polysorbates
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer Nanoxel M, Taxotere, Doxorubicin - Breast Cancer | Phase 3 | Terminated | Samyang Biopharmaceuticals Corporation | 26 | 2022-03-31 | 2024-05-17 |
| Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC Nanoxel®M, Mitomycin-C - Non Muscle Invasive Bladder Cancer | Phase 3 | Terminated | Samyang Biopharmaceuticals Corporation | 36 | 2017-01-01 | 2019-08-30 |
| Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants 13 valent pneumococcal conjugate vaccine with Polysorbate 80, 13 valent pneumococcal conjugate vaccine without Polysorbate 80 - Vaccines, Pneumococcal | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 500 | 2006-11-01 | 2012-08-15 |
Breast Neoplasms (1) · Carcinoma, Transitional Cell (1) · Non-Muscle Invasive Bladder Neoplasms (1)
Samyang Biopharmaceuticals Corporation (2) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
South Korea (2) · Poland (1)
Ja Hyeon Ku (1) · Joohyuk Sohn, M.D.,Ph.D. (1)